Universal Therapeutics Diagnostics Sdn Bhd receives formal approval from Medical Device Authority (MDA), Malaysia our in-house manufacturing licence
For Immediate Release
1 November 2022
Kuala Lumpur, Malaysia, 1 November 2022- Universal Therapeutics Diagnostics Sdn Bhd (“UTD”) receives the official nod from its competent and governing authority Medical Device Authority (MDA, Ministry of Health), Malaysia to commence her In- Vitro Diagnostics (“IVD”) production in its own facility.
Proudly “In-house” and “Made in Malaysia”, the plant boasts a menu of IVDs for medical practitioners and home users. UTD’s current focus will be pregnancy, infectious diseases, drug, dengue, and malaria IVDs.
Apart from serving the Malaysian domestic market, UTD also has orders from other countries to provide OEM and ODM services to meet their needs.
Dato’ Sri Samuel Chai, Chief Executive Officer of UTD shares, “The driver behind this facility is to provide Accurate, Precise and Simple solutions. Covid-19 has shared an experience with us to never take for granted accurate and simple testing at the comfort of our own space”.
As part of the roadmap to improve and to stay ahead of the growing needs in the market and her product offering, the facility is developing it’s own research and development laboratory.
For more information, please contact:
Cassandra Bowden (Miss)
External Communications Executive
Email: cas@universal-therapeutics.com
Tel.: +60 3 9213 0318
About Universal Therapeutics Diagnostics Sdn Bhd
Established in 2021, UTD’s core focus is in the manufacturing and distribution of In-Vitro Diagnostics (IVD). UTD has her own manufacturing facility in Malaysia focused on pregnancy, infectious diseases, drug, dengue, and malaria IVDs. UTD also provides OEM and ODM services. UTD has been certified as a distributor with GDPMD by SGS and as a manufacturer by Medical Device Authority (MDA, Ministry of Health Malaysia).